Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitex trifolia extract is a botanical extract derived from the *Vitex trifolia* plant, a species traditionally utilized in Chinese medicine. It is currently being investigated for its multi-target neuroprotective and anti-inflammatory properties, particularly in the context of Alzheimer's disease (AD) and gut-brain axis dysfunction. The extract contains numerous bioactive compounds (approximately 27 identified via HPLC) that modulate several critical signaling pathways. Its mechanism of action involves the activation of the PI3K/Akt/GSK-3β and AMPK signaling pathways, which collectively work to inhibit the accumulation of amyloid-beta (Aβ) and the hyperphosphorylation of tau proteins. Furthermore, the extract demonstrates the ability to reduce oxidative stress, maintain mitochondrial membrane potential, and inhibit acetylcholinesterase activity. Preclinical studies also suggest it may improve intestinal barrier integrity and mitigate both central and peripheral immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitex trifolia extract.